Neomatrix Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.61M

  • Investors
  • 4

Neomatrix General Information

Description

Developer of an immunotherapy cancer vaccine designed to eliminate tumor cells in the body. The company specializes in unique, in-depth knowledge of cancer biology and Immuno-Oncology, advanced technologies to identify patients' tumor neoantigens, design and production of fully synthetic, personalized DNA vaccines, and a potent delivery system to maximize the immune response, enabling health professionals to track early symptoms of cancer.

Contact Information

Website
www.neomatrixbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via di Castel Romano, 100
  • 00128 Rome
  • Italy
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Via di Castel Romano, 100
  • 00128 Rome
  • Italy

Neomatrix Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neomatrix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 21-Nov-2024 $1.61M Completed Generating Revenue
2. Seed Round 05-Jun-2023 Completed Generating Revenue
1. Spin-Off 01-Jan-2020 Completed Startup
To view Neomatrix’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Neomatrix Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Neomatrix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026099285-A1 Cancer vaccines Pending 05-Nov-2024

Neomatrix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neomatrix Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Deutsche Balaton Family Office Minority
4basebio Corporation Minority
I2I Capitals Angel Group Minority
Takis Biotech VC-Backed Company Minority
To view Neomatrix’s complete investors history, request access »

Ready to get started?

Request a free trial

Neomatrix FAQs

  • When was Neomatrix founded?

    Neomatrix was founded in 2020.

  • Where is Neomatrix headquartered?

    Neomatrix is headquartered in Rome, Italy.

  • What is the size of Neomatrix?

    Neomatrix has 9 total employees.

  • What industry is Neomatrix in?

    Neomatrix’s primary industry is Drug Discovery.

  • Is Neomatrix a private or public company?

    Neomatrix is a Private company.

  • What is the current valuation of Neomatrix?

    The current valuation of Neomatrix is .

  • What is Neomatrix’s current revenue?

    The current revenue for Neomatrix is .

  • How much funding has Neomatrix raised over time?

    Neomatrix has raised $3.78M.

  • Who are Neomatrix’s investors?

    Deutsche Balaton, 4basebio, I2I Capitals, and Takis Biotech have invested in Neomatrix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process